Centro de Investigaciones en Bionanociencias-"Elizabeth Jares-Erijman" (CIBION), CONICET, Godoy Cruz 2390, 1425 Ciudad de Buenos Aires, Argentina.
Phys Chem Chem Phys. 2018 Nov 28;20(46):29212-29220. doi: 10.1039/c8cp06196c.
Class B G protein-coupled receptors (GPCRs) are involved in a variety of human pathophysiological states. These groups of membrane receptors are less studied than class A GPCRs due to the lack of structural information, delayed small molecule drug discovery, and scarce fluorescence detection tools available. The class B corticotropin-releasing hormone type 1 receptor (CRHR1) is a key player in the stress response whose dysregulation is critically involved in stress-related disorders: psychiatric conditions (i.e. depression, anxiety, and addictions), neuroendocrinological alterations, and neurodegenerative diseases. Here, we present a strategy to label GPCRs with a small fluorescent antagonist that permits the observation of the receptor in live cells through stochastic optical reconstruction microscopy (STORM) with 23 nm resolution. The marker, an aza-BODIPY derivative, was designed based on computational docking studies, then synthesized, and finally tested in biological cells. Experiments on hippocampal neurons demonstrate antagonist effects in similar concentrations as the well-established antagonist CP-376395. A quantitative analysis of two color STORM images enabled the determination of the binding affinity of the new marker in the cellular environment.
B 类 G 蛋白偶联受体 (GPCR) 参与了多种人类病理生理状态。由于缺乏结构信息、小分子药物发现延迟以及可用的荧光检测工具稀缺,这些膜受体的研究不如 A 类 GPCR 广泛。B 类促肾上腺皮质激素释放激素 1 型受体 (CRHR1) 是应激反应的关键参与者,其功能失调与应激相关障碍密切相关:精神疾病(如抑郁、焦虑和成瘾)、神经内分泌改变和神经退行性疾病。在这里,我们提出了一种用小分子荧光拮抗剂标记 GPCR 的策略,该策略允许通过随机光学重建显微镜 (STORM) 以 23nm 的分辨率观察活细胞中的受体。该标记物是一种氮杂-BODIPY 衍生物,基于计算对接研究设计,然后合成,并最终在生物细胞中进行测试。在海马神经元上的实验表明,该拮抗剂在与成熟的拮抗剂 CP-376395 相似的浓度下具有拮抗剂作用。双色 STORM 图像的定量分析能够确定新标记物在细胞环境中的结合亲和力。